A recent U.S. Food
and Drug Administration report presented
the
currently available scientific information related to biological
response to metal implants. In this work, a multilevel approach was
employed to assess the implant-induced and biocorrosion-related inflammation
in the adjacent vascular tissue using a mouse stent implantation model.
The implications of biocorrosion on peri-implant tissue were assessed
at the macroscopic level via in vivo imaging and
histomorphology. Elevated matrix metalloproteinase activity, colocalized
with the site of implantation, and histological staining indicated
that stent surface condition and implantation time affect the inflammatory
response and subsequent formation and extent of neointima. Hematological
measurements also demonstrated that accumulated metal particle contamination
in blood samples from corroded-stetted mice causes a stronger immune
response. At the cellular level, the stent-induced alterations in
the nanostructure, cytoskeleton, and mechanical properties of circulating
lymphocytes were investigated. It was found that cells from corroded-stented
samples exhibited higher stiffness, in terms of Young’s modulus
values, compared to noncorroded and sham-stented samples. Nanomechanical
modifications were also accompanied by cellular remodeling, through
alterations in cell morphology and stress (F-actin) fiber characteristics.
Our analysis indicates that surface wear and elevated metal particle
contamination, prompted by corroded stents, may contribute to the
inflammatory response and the multifactorial process of in-stent restenosis.
The results also suggest that circulating lymphocytes could be a novel
nanomechanical biomarker for peri-implant tissue inflammation and
possibly the early stage of in-stent restenosis. Large-scale studies
are warranted to further investigate these findings.